Europska Unija - hrvatski - EMA (European Medicines Agency)

ceva santé animale - prigušeno virusni cjepivo protiv bjesnoće u želuci, soj spbn gasgas - imunomodulatori za pasa, živa virusna cjepiva - red foxes (vulpes vulpes); raccoon dogs (nyctereutes procyonoides) - za aktivnu imunizaciju lisica i rakunovaca protiv bjesnoće kako bi se spriječila infekcija i smrtnost.

Europska Unija - hrvatski - EMA (European Medicines Agency)

nova laboratories ireland limited - hidroksikarbamid - anemija, sickle cell - antineoplastična sredstva - prevencija сосудисто-jamice komplikacija anemija srpastih stanica anemije u bolesnika starijih od 2 godine.

Europska Unija - hrvatski - EMA (European Medicines Agency)

laboratorios hipra s.a. - živa аттенуированная респираторно-синцитиальный virus goveda (brsv), procijediti Лым-56 - imunomodulatori za bika, goveda, živa virusna cjepiva, bika респираторно-синцитиальный virus (brsv) - stoka - aktivna imunizacija goveda, da se smanji izlučivanje virusa i respiratornih kliničkih znakova, uzrokovane респираторно-синцитиальной infekcije goveda .

Europska Unija - hrvatski - EMA (European Medicines Agency)

intervet international b.v. - Živjeti миксома vektor soj virusa РЖС 009, Živa vektor миксомы soj virusa mk1899 ПРРЛ - imunomodulatori za зайцевые - kunići - za aktivna imunizacija kunića od 5 tjedana starosti i dalje, da se smanji smrtnost i klinički znakovi miksomatozom kunića i hemoragijske bolesti (ПРК), uzrokovana virusom klasične ПРК (rhdv1) i tip ПРК virus 2 (rhdv2).

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - рекомбинантный virus везикулярного стоматита (soj indiana) s brisanje koverti glikoprotein, zamijenjen zair ebole (soj киквите 1995) površinski glikoprotein - Геморрагическая groznice ebole - cjepiva - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. korištenje ervebo moraju biti u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - odbacivanje transplantata - imunosupresivi - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Europska Unija - hrvatski - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bayer ag - koncentrat za suspenziju (sc) - fluopiram 400g/l

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

zoetis b.v. podružnica zagreb za promidžbu, petra hektorovića 2, zagreb, hrvatska - živi atenuirani virus zaraznog bronhitisa ptica, soj h120; živi atenuirani virus zaraznog bronhitisa ptica, soj d274 klon - liofilizat za suspenziju - imunološki pripravci za ptice, živo virusno cjepivo za kokoši, virus zaraznog bronhitisa ptica - kokoši

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - živi, lentogeni virus newcastleske bolesti, soj la sota - liofilizat za suspenziju - imunološki vmp - kokoši, purana